HealthEquity Price to Sales Ratio 2014-2024 | HQY
Historical PS ratio values for HealthEquity (HQY) over the last 10 years. The current P/S ratio for HealthEquity as of September 27, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| HealthEquity P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-09-26 | 78.64 | 6.28 | |
| 2024-07-31 | 78.48 | $12.52 | 6.27 |
| 2024-04-30 | 78.91 | $11.95 | 6.60 |
| 2024-01-31 | 75.58 | $11.54 | 6.55 |
| 2023-10-31 | 71.68 | $11.29 | 6.35 |
| 2023-07-31 | 67.94 | $10.98 | 6.19 |
| 2023-04-30 | 53.45 | $10.60 | 5.04 |
| 2023-01-31 | 60.85 | $10.21 | 5.96 |
| 2022-10-31 | 77.91 | $9.89 | 7.88 |
| 2022-07-31 | 58.17 | $9.49 | 6.13 |
| 2022-04-30 | 62.32 | $9.31 | 6.69 |
| 2022-01-31 | 53.44 | $9.12 | 5.86 |
| 2021-10-31 | 66.18 | $9.16 | 7.23 |
| 2021-07-31 | 73.98 | $9.31 | 7.95 |
| 2021-04-30 | 75.97 | $9.48 | 8.02 |
| 2021-01-31 | 83.55 | $9.85 | 8.48 |
| 2020-10-31 | 51.49 | $10.30 | 5.00 |
| 2020-07-31 | 51.56 | $10.23 | 5.04 |
| 2020-04-30 | 56.27 | $9.12 | 6.17 |
| 2020-01-31 | 66.06 | $7.85 | 8.42 |
| 2019-10-31 | 56.79 | $6.11 | 9.30 |
| 2019-07-31 | 81.98 | $4.98 | 16.46 |
| 2019-04-30 | 67.75 | $4.78 | 14.17 |
| 2019-01-31 | 62.34 | $4.53 | 13.75 |
| 2018-10-31 | 91.80 | $4.32 | 21.27 |
| 2018-07-31 | 75.50 | $4.13 | 18.28 |
| 2018-04-30 | 65.67 | $3.93 | 16.71 |
| 2018-01-31 | 50.62 | $3.72 | 13.61 |
| 2017-10-31 | 50.22 | $3.52 | 14.25 |
| 2017-07-31 | 45.87 | $3.33 | 13.79 |
| 2017-04-30 | 45.52 | $3.15 | 14.47 |
| 2017-01-31 | 46.25 | $2.99 | 15.49 |
| 2016-10-31 | 33.23 | $2.81 | 11.81 |
| 2016-07-31 | 29.52 | $2.61 | 11.32 |
| 2016-04-30 | 25.15 | $2.38 | 10.55 |
| 2016-01-31 | 21.55 | $2.16 | 9.98 |
| 2015-10-31 | 32.71 | $2.03 | 16.12 |
| 2015-07-31 | 33.66 | $1.89 | 17.78 |
| 2015-04-30 | 26.21 | $1.88 | 13.96 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $6.980B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $121.497B | 14.81 |
| Cencora (COR) | United States | $44.320B | 16.94 |
| ICON (ICLR) | Ireland | $23.561B | 21.17 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Avantor (AVTR) | United States | $17.560B | 26.63 |
| Natera (NTRA) | United States | $15.549B | 0.00 |
| Revvity (RVTY) | United States | $15.548B | 27.23 |
| Viatris (VTRS) | United States | $13.785B | 4.20 |
| CochLear (CHEOY) | Australia | $12.759B | 0.00 |
| Solventum (SOLV) | United States | $11.670B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.275B | 31.18 |
| Charles River Laboratories (CRL) | United States | $10.239B | 19.35 |
| Sonic Healthcare (SKHHY) | Australia | $9.066B | 0.00 |
| Doximity (DOCS) | United States | $7.965B | 50.47 |
| Bausch + Lomb (BLCO) | Canada | $6.671B | 28.71 |
| PACS (PACS) | United States | $6.029B | 0.00 |
| Organon (OGN) | United States | $4.938B | 5.02 |
| Life Times (LTH) | United States | $4.827B | 40.35 |
| Sotera Health (SHC) | United States | $4.747B | 23.94 |
| Surgery Partners (SGRY) | United States | $4.058B | 44.96 |
| Concentras Parent (CON) | United States | $2.838B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.613B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.599B | 97.86 |
| BrightSpring Health Services (BTSG) | United States | $2.570B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.194B | 0.00 |
| Premier (PINC) | United States | $2.003B | 9.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.961B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.618B | 8.12 |
| CareDx (CDNA) | United States | $1.566B | 0.00 |
| Agilon Health (AGL) | United States | $1.539B | 0.00 |
| Progyny (PGNY) | United States | $1.517B | 26.67 |
| Teladoc Health (TDOC) | United States | $1.449B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.314B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.153B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.123B | 29.39 |
| Pediatrix Medical (MD) | United States | $0.967B | 10.52 |
| Embecta (EMBC) | United States | $0.817B | 5.45 |
| InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
| Sharecare (SHCR) | United States | $0.524B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.466B | 0.00 |
| Enhabit (EHAB) | United States | $0.399B | 34.48 |
| Sonida Senior Living (SNDA) | United States | $0.378B | 0.00 |
| DocGo (DCGO) | United States | $0.346B | 13.00 |
| Sera Prognostics (SERA) | United States | $0.256B | 0.00 |
| Biodesix (BDSX) | United States | $0.248B | 0.00 |
| LifeMD (LFMD) | United States | $0.224B | 0.00 |
| ModivCare (MODV) | United States | $0.200B | 6.34 |
| Ascend Wellness Holdings (AAWH) | United States | $0.181B | 0.00 |
| Beauty Health (SKIN) | United States | $0.171B | 0.00 |
| MultiPlan (MPLN) | United States | $0.118B | 0.00 |
| Nutex Health (NUTX) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 22.49 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.087B | 0.00 |
| SBC Medicals (SBC) | United States | $0.050B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.039B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.029B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.018B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | $0.007B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |